Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
Walsh
Patrick C
PC
D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000728:Androgens / Q000502:physiology*; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000191:economics / Q000628:therapy*; D009376:Neoplasms, Hormone-Dependent / Q000191:economics / Q000628:therapy*; D009919:Orchiectomy / Q000191:economics; D010166:Palliative Care / Q000191:economics; D011471:Prostatic Neoplasms / Q000191:economics / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic
D000726:Androgen Antagonists; D000728:Androgens